Drug · DIN 02408007
FENTORA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 22, 2026; first marketed May 14, 2014.
- Drug Identification Number (DIN)
- 02408007
- Company (DIN owner)
- Phoenix Labs Unlimited CompanyDublin, Ireland
- Schedule
- Narcotics (cdsa i)
- Dosage form
- Tablet (Effervescent)
- Route
- Sublingual; Buccal
- Therapeutic class (ATC)
- Fentanyl N02AB03
- Class
- Human
- Record last updated
- July 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FENTANYL (FENTANYL CITRATE) | 100 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 22, 2026: NOC 37952New Drug Submission (NDS) · Administrative: Change in product ownership
- November 21, 2013: NOC 14928New Drug Submission (NDS) · Manufacturer name change
- June 14, 2013: NOC 14469New Drug Submission (NDS)
Other DINs named FENTORA
- DIN 02408015 · Marketed
- DIN 02408023 · Marketed
- DIN 02408031 · Marketed
- DIN 02408058 · Marketed